Urinary Incontinence Devices Market – Trends Forecast Till 2031

Market Snapshot

Market Overview

The global Urinary Incontinence Devices Market size was estimated at USD 4,220 million in 2024 and is projected to reach USD 7,615.78 million in 2031 at a CAGR of 8.8 % during the forecast period 2025-2031.

The urinary incontinence devices market refers to the segment of healthcare products designed to manage and treat urinary incontinence, a condition where individuals lose control over their bladder. This market includes a variety of devices such as absorbent pads, catheters, external collection devices, and electrical stimulation devices, which help patients maintain comfort and hygiene. Urinary incontinence can occur due to various reasons, such as aging, pregnancy, surgery, neurological disorders, and certain lifestyle factors. The increasing prevalence of these conditions, particularly in the aging global population, has led to a growing demand for solutions that can effectively manage symptoms and improve quality of life.

The scope of the urinary incontinence devices market spans across different product categories and patient needs. Absorbent products, such as adult diapers and incontinence pads, are widely used, especially in elderly populations. Moreover, more advanced devices like catheters and neuromodulation devices cater to individuals with severe incontinence or neurological impairments. The market also includes diagnostics, therapeutics, and support devices aimed at both short-term and long-term management. As the market evolves, there is increasing emphasis on developing devices that provide comfort, convenience, and dignity for users while being discreet and effective.

Key trends shaping the urinary incontinence devices market include the growing adoption of minimally invasive devices, increasing awareness of incontinence management options, and a shift toward more personalized solutions. Innovations in smart incontinence products, such as those with built-in sensors that monitor fluid levels or track usage, are becoming more prevalent. Additionally, the integration of digital technologies, including mobile apps for remote monitoring and communication with healthcare providers, is enhancing patient care. The rising demand for these advanced devices reflects a shift toward improving both clinical outcomes and user experience.

Several drivers are contributing to the growth of the urinary incontinence devices market. The aging global population is a significant factor, as older individuals are more prone to developing urinary incontinence. Rising awareness about the condition and its treatment options has led to greater acceptance of incontinence management products. Additionally, improvements in product design, such as more discreet and comfortable materials, have increased consumer confidence. Moreover, the ongoing development of new technologies and therapies aimed at treating the underlying causes of incontinence, such as neuromodulation or regenerative medicine, is expected to drive further market expansion.

Delvens Industry Expert's Standpoint

Experts in the Urinary Incontinence Devices Market highlight several key trends driving growth and innovation. The urinary incontinence devices market involves products designed to manage and treat urinary incontinence, including absorbent pads, catheters, external collection devices, and electrical stimulation devices. The growing prevalence of conditions leading to incontinence, particularly among the aging population, drives market demand. Key trends include the rise of minimally invasive and smart devices, along with increased awareness and personalization in solutions. The market is further propelled by advancements in technology, such as digital monitoring and improved product designs that focus on comfort and discretion. With aging populations and ongoing innovations, the market is expected to continue expanding, offering more effective and user-friendly options for managing incontinence.

Market Portfolio

Key Findings

• Female patients represented the largest share of the urinary incontinence devices market. This market is divided by patient type into male and female categories, with female patients leading due to factors such as pregnancy, childbirth, menopause, and hormonal fluctuations, which increase the risk of incontinence. Conditions like stress urinary incontinence (SUI) are more common among women, driving demand for incontinence management products. Additionally, growing awareness, higher healthcare spending, and advancements in minimally invasive treatments have contributed to the growth of this market segment.

• Hospitals dominated the urinary incontinence devices market terms of end users. The market is divided into hospitals, physician offices, and other settings like ambulatory surgical centers (ASCs) and homecare environments. Hospitals held the largest share, supported by their advanced medical infrastructure, high volume of surgical procedures, and the availability of specialized healthcare providers. With the capacity to offer a wide range of treatments, such as urethral and vaginal sling placements and artificial urinary sphincter insertions, hospitals are often the preferred choice for patients. However, the rising incidence of catheter-associated urinary tract infections (CAUTIs) has led to restrictions on the long-term use of urinary catheters in hospitals.

• The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America region is projected to hold the largest market share. Factors such as increasing prevalence of urinary incontinence, an aging population, greater awareness, technological advancements, rising healthcare expenditures, improved diagnostics, expanding infrastructure, product innovations, demand for minimally invasive treatments, and government support have triggered the Urinary Incontinence Devices Market in the region.

Regional Analysis

North America to Dominate the Market

• The North American urinary incontinence devices market is characterized by a high demand for advanced healthcare solutions driven by a large aging population and increasing awareness of incontinence conditions. The United States, in particular, has seen a rise in the adoption of innovative urinary incontinence devices due to the availability of advanced healthcare infrastructure and high healthcare spending. Additionally, the region's strong focus on research and development, along with favorable reimbursement policies, is likely to continue fueling growth in this market.

• In Europe, the urinary incontinence devices market is influenced by a well-established healthcare system, particularly in countries like Germany, the UK, and France. Growing awareness around urinary incontinence, coupled with increasing healthcare expenditures, has led to an uptick in demand for these devices. Furthermore, Europe has a substantial elderly population, and trends toward more personalized healthcare solutions are encouraging the growth of innovative urinary incontinence devices.

• The Asia-Pacific region is expected to see substantial growth in the urinary incontinence devices market, largely due to the rapidly aging population in countries like Japan, China, and India. Additionally, rising disposable income, improvements in healthcare access, and increased awareness of incontinence issues are driving demand. However, cultural factors and a lack of widespread knowledge about incontinence may present challenges to the market's growth in certain countries.

• Latin America’s urinary incontinence devices market is slowly expanding, driven by an aging population and gradual improvements in healthcare systems across the region. Despite these improvements, market growth is often hindered by economic constraints and limited awareness of incontinence-related health issues. However, there is potential for growth as governments and organizations work toward enhancing healthcare infrastructure and education in this area.

• In the Middle East & Africa, the urinary incontinence devices market is relatively underdeveloped but shows signs of growth due to an increasing awareness of healthcare issues and improvements in medical care, particularly in the Gulf Cooperation Council (GCC) countries. Factors such as rapid urbanization, rising healthcare investments, and a growing elderly population contribute to the potential for market expansion in this region. However, challenges related to healthcare access in rural areas and socio-cultural stigmas still pose barriers.

Competitive Landscape

• Coloplast Corp
• B. Braun SE
• Johnson & Johnson Services, Inc.
• Convatec Inc.
• Boston Scientific Corporation
• Hollister Incorporated
• Becton, Dickinson and Company (BD)
• Cook Group
• Cardinal Health
• Laborie
• Medtronic
• Teleflex Incorporated
• Caldera Medical Inc.
• AdvaCare Pharma
• MRK Healthcare Pvt. Ltd.
• Advin Health Care
• CliniMed Limited
• Sterimed Group
• Kimberly-Clark Corporation (KCWW)
• Wellspect HealthCare
• InControl Medical
• Zephyr Surgical Implants
• Flexicare (Group) Limited
• Dynarex Corporation
• Stryker

Recent Developments

• Following the successful launch of Luja with Micro-hole Zone Technology, a next-generation intermittent catheter for men, Coloplast is now introducing Luja for women. Utilizing the same innovative technology, the female version will be rolled out across Coloplast's major markets over the next 12 months, starting with Denmark and Italy in May 2024.

• In February 2022, Medtronic received FDA approval for the InterStim X, its latest recharge-free device in the InterStim range for commercial use. The InterStim systems provide sacral neuromodulation (SNM) therapy for patients dealing with bladder and bowel disorders.

• In November 2024, Boston Scientific Corporation completed its acquisition of Axonics, Inc., a medical technology company known for its groundbreaking devices that treat urinary and bowel dysfunction, as well as offer urethral bulking for women. This acquisition bolsters Boston Scientific's leadership in sacral neuromodulation, an expanding segment within its Urology division.

• In November 2023, Coloplast invested approximately USD 100.5 million (700 million DKK) in a new factory in Portugal to support its future growth. The factory will produce intermittent catheters for patients with urinary retention, including those with spinal cord injuries or spina bifida. This investment responds to the rising global demand, particularly in Europe.

Reasons to Acquire

• Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
• Gain authentic and granular data access for the Urinary Incontinence Devices Market to understand the trends and the factors involved in changing market situations.
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope